Back
Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
VRCA
Sponsored
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Buy
55
VRCA
Verrica Pharmaceuticals
Last Price:
6.88
Seasonality Move:
-18.7%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!Verrica Pharmaceuticals Price Quote
$6.88
+0.12 (+1.78%)
(Updated: May 3, 2024 at 1:05 PM ET)
Verrica Pharmaceuticals Key Stats
Buy
55
Verrica Pharmaceuticals (VRCA)
is a Buy
Day range:
$6.54 - $6.97
52-week range:
$2.86 - $7.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
59.81
P/B ratio:
14.51%
Volume:
160.1K
Avg. volume:
188.7K
1-year change:
9.21%
Market cap:
$286.8M
Revenue:
$5.1M
EPS:
$-1.47
How Much Does Verrica Pharmaceuticals Make?
-
How Much Are Verrica Pharmaceuticals's Sales Annually?
VRCA Revenues are $5.1M -
How Much Profit Does Verrica Pharmaceuticals's Make A Year?
VRCA net income is -$67M
Is Verrica Pharmaceuticals Growing As A Company?
-
What Is Verrica Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 28.24% -
What Is Verrica Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Verrica Pharmaceuticals Stock Price Performance
-
Did Verrica Pharmaceuticals Stock Go Up Last Month?
Verrica Pharmaceuticals share price went up by 14.77% last month -
Did VRCA's Share Price Rise Over The Last Year?
VRCA share price rose by 9.21% over the past 1 year
What Is Verrica Pharmaceuticals 52-Week High & Low?
-
What Is Verrica Pharmaceuticals’s 52-Week High Share Price?
Verrica Pharmaceuticals has traded as high as $7.76 over the past 52 weeks -
What Is Verrica Pharmaceuticals’s 52-Week Low Share Price?
Verrica Pharmaceuticals has traded as low as $2.86 over the past 52 weeks
Verrica Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Verrica Pharmaceuticals?
-
How Much Debt Does Verrica Pharmaceuticals Have?
Total long term debt quarterly is $42.9M -
How Much Cash Does Verrica Pharmaceuticals Have?
Cash and short term investments quarterly total is $69.5M -
What Is Verrica Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.47
Is Verrica Pharmaceuticals Cash Flow Positive?
-
What Is VRCA Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.6M -
What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $74.2M -
What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$362K
Verrica Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
VRCA return on invested capital is -108.89% -
What Is Verrica Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -94.54% -
What Is VRCA Return On Equity?
ROE is a measure of profitability and is -150.66%
Verrica Pharmaceuticals Earnings Date & Stock Price
-
What Is Verrica Pharmaceuticals's Stock Price Today?
A single share of VRCA can be purchased today for 6.76 -
What Is Verrica Pharmaceuticals’s Stock Symbol?
Verrica Pharmaceuticals trades on the nasdaq under the ticker symbol: VRCA -
When Is Verrica Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Verrica Pharmaceuticals is scheduled on May 9, 2024 -
When Is VRCA's next ex-dividend date?
Verrica Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Verrica Pharmaceuticals Stock?
You can buy Verrica Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Verrica Pharmaceuticals Competitors
-
Who Are Verrica Pharmaceuticals's Competitors?
Below is a list of companies who compete with Verrica Pharmaceuticals or are related in some way:
Verrica Pharmaceuticals Dividend Yield
Data Unavailable
Verrica Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 5.69% |
Revenue: | 2823.53% | 109.71% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 13.60 |
Upside from Last Price: | 101.18% |